These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36283815)

  • 1. Treatment of giant cell arteritis - current approach and new possibilities.
    Videman J; Skácelová M; Horák P; Skoumalová A; Hraboš D
    Vnitr Lek; 2022; 68(5):266-272. PubMed ID: 36283815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
    Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of polymyalgia rheumatica and large vessel vasculitis].
    Hellmich B
    Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of giant cell arteritis.
    González-Gay MÁ; Pina T; Prieto-Peña D; Calderon-Goercke M; Gualillo O; Castañeda S
    Biochem Pharmacol; 2019 Jul; 165():230-239. PubMed ID: 31034796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant cell arteritis: epidemiology, diagnosis, and management.
    Gonzalez-Gay MA; Martinez-Dubois C; Agudo M; Pompei O; Blanco R; Llorca J
    Curr Rheumatol Rep; 2010 Dec; 12(6):436-42. PubMed ID: 20857242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell arteritis.
    Pepper K
    Postgrad Med; 2023 Jan; 135(sup1):22-32. PubMed ID: 37021621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyalgia Rheumatica and Giant Cell Arteritis.
    Buttgereit F; Matteson EL; Dejaco C
    JAMA; 2020 Sep; 324(10):993-994. PubMed ID: 32897333
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
    Clifford AH; Murphy EM; Burrell SC; Bligh MP; MacDougall RF; Heathcote JG; Castonguay MC; Lee MS; Matheson K; Hanly JG
    J Rheumatol; 2017 Dec; 44(12):1859-1866. PubMed ID: 28916549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study.
    Tomelleri A; Campochiaro C; Farina N; Mariotti L; Baldissera E; Grayson PC; Matucci-Cerinic M; Dagna L
    Semin Arthritis Rheum; 2023 Apr; 59():152174. PubMed ID: 36774660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis and classification of giant cell arteritis.
    Nesher G
    J Autoimmun; 2014; 48-49():73-5. PubMed ID: 24461386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study.
    Schönau V; Roth J; Tascilar K; Corte G; Manger B; Rech J; Schmidt D; Cavallaro A; Uder M; Crescentini F; Boiardi L; Casali M; Spaggiari L; Galli E; Kuwert T; Versari A; Salvarani C; Schett G; Muratore F
    Rheumatology (Oxford); 2021 Aug; 60(8):3851-3861. PubMed ID: 33831144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
    Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
    RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in giant cell arteritis.
    Frohman L; Wong AB; Matheos K; Leon-Alvarado LG; Danesh-Meyer HV
    Surv Ophthalmol; 2016; 61(4):400-21. PubMed ID: 26774550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging diagnosis tools and therapeutics for giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Rev Clin Immunol; 2018 Jul; 14(7):593-605. PubMed ID: 29877748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Perspectives in Giant Cell Arteritis: Can We Better Connect Pathogenesis and Treatment?
    Opriș-Belinski D; Cobilinschi CO; Săulescu I
    Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Large-vessel vasculitis-giant cell and Takayasu arteritis].
    Villiger PM
    Internist (Berl); 2019 Oct; 60(10):1059-1073. PubMed ID: 31471629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of giant cell arteritis].
    Greigert H; Bonnotte B; Samson M
    Rev Prat; 2023 Apr; 73(4):387-394. PubMed ID: 37289151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.